Iwatsuki S, Shaw B W, Starzl T E
Ann Surg. 1983 Mar;197(3):247-53. doi: 10.1097/00000658-198303000-00001.
One hundred fifty liver resections were performed with an operative mortality rate of 4%. Indications for liver resections were 43 primary liver malignancies, 43 metastatic liver tumors, and 64 benign liver diseases. The 3-year actuarial survival rate after treatment of primary liver malignancy was 56%, and that after treatment of metastatic liver tumors was 66%. All but one of 59 patients with benign disease who survived operation were alive without development of late symptoms or complications.
共进行了150例肝切除术,手术死亡率为4%。肝切除术的适应证包括43例原发性肝癌、43例肝转移瘤和64例良性肝病。原发性肝癌治疗后的3年精算生存率为56%,肝转移瘤治疗后的3年精算生存率为66%。59例良性疾病患者中,除1例死亡外,其余存活患者均未出现晚期症状或并发症。